A RANDOMIZED, DOUBLE BLIND, PARALLEL GROUP, PHASE 1 STUDY TO DEMONSTRATE THE EQUIVALENCE WITH RESPECT TO THE PHARMACOKINETIC PROFILE OF CT-P13 AND REMICADE IN PATIENTS WITH ANKYLOSING SPONDYLITIS.

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2010
This article has no abstract
Epistemonikos ID: 1e6f023cdc9130def7fe49339226584c95c0eeee
First added on: Apr 16, 2025